(Q35756123)

10 August 2017

title

Measured human dosimetry of 68Ga-DOTATATE. (English)

1 reference

10 August 2017

Ronald C Walker

1

1 reference

10 August 2017

Gary T Smith

2

1 reference

10 August 2017

Eric Liu

3

1 reference

10 August 2017

Brandon Moore

4

1 reference

10 August 2017

Jeff Clanton

5

1 reference

10 August 2017

Michael Stabin

6

1 reference

10 August 2017

language of work or name

English

0 references

publication date

20 March 2013

1 reference

The Journal of Nuclear Medicine

10 August 2017

published in

1 reference

10 August 2017

volume

54

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

855-860

1 reference

Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapy

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

Peptide-receptor radionuclide therapy for endocrine tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

[Radiation exposure of patients during 68Ga-DOTATOC PET/CT examinations].

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

Physical models and dose factors for use in internal dose assessment

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472480

Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide

15 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23516312

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Developing and testing integrated multicompartment models to describe a single-input multiple-output study using the SAAM II software system

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23516312

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23516312

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2967/JNUMED.112.114165

1 reference

10 August 2017

1 reference

10 August 2017

1 reference